retatrutide weight loss trials VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide — a promising new

Do not consume more than 2 serves per day

GLP-1 drugs have been linked to several eye problems, including: Non-arteritic anterior ischemic optic neuropathy (NAION) Optic neuropathy Retinal ischemia Exacerbation of diabetic retinopathy These GLP-1 eye problems can range from mild visual field defects to complete blindness in one eye

Ipamorelin and bone health Ipamorelin seems to also improve bone growth and formation [18]

Our data complements another recent study that came to a similar conclusion showing that GLP-1 drugs reduced risk of cardiovascular death and death due to infectious causes, primarily COVID-19

Oral semaglutide (25 mg) has shown weight-loss results similar to Wegovy (2.4 mg)